Helixgate https://validator.w3.org/feed/docs/rss2.html Home Albumin-Fused Antibodies May Reduce Fetal Exposure to Therapeutics Malaria Mosquito Bites Turned Into Immune Boosters in New Chemovaccination Strategy Advancing Microbial-Derived Biologics from Scale-Up to Commercial Production STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise University of Rhode Island Wins Grant to Study Cerebral Amyloid Angiopathy Prevalent in Alzheimer’s Patients The Microbiome Field Enters Its Next Chapter Pharma Races to Scale AI as Billions Flow into Drug Discovery Argenx jumps on Phase 3 data for blockbuster Vyvgart EyePoint plummets on pivotal data for main drug Roundup: Removing Impurities from Biomanufacturing STAT+: The IRS is probing UnitedHealth, and a private equity slowdown EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit Your AI Is Only as Good as Your Inputs STAT+: Commure terminates payments under its customer referral programs tied to AI products AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak Everything the Trump administration did on health care last week Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact J&J hands lymphoma bispecific CAR T back to AbelZeta Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map Italian biotech gains momentum as VC funding, tech transfer environment improve How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine STAT+: State laws may be curbing private equity takeovers of physician group Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators Opinion: AAP president: How pediatricians are navigating federal leaders’ fear-mongering on vaccines Luigi Mangione pleads guilty to federal stalking charges in the killing of UnitedHealthcare CEO Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris Capricor soars on potential FDA review extension, filing amendments SFA Spectroscopy Chases Away Cloudy Samples STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism This week in Drug Discovery (10-14 August 2026)  Skye and Redx form new entity with $125M to advance fibrosis assets STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class BMS welcomes new multiple myeloma drug as generics batter current portfolio Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study Biotech initiatives pick up as more regions race to become hubs Two years after rules overhaul, have methadone clinics really changed? Nascent US psychedelic therapy opportunity attracts overseas manufacturers Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy Dynamism and evolvability in nucleic acid enzymes New Taiho, Cullian data heats up lung cancer drug battle CDMOs Expand and Build for Future Growth Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition CN Bio awarded Innovate UK grant to reduce animal testing Automated synthetic cell-based screening for designed proteins with emergent functions